New injection tested to tame severe teen eczema
NCT ID NCT06495229
Summary
This study is testing an investigational drug called CM310 to see if it is safe and effective for teenagers with moderate-to-severe atopic dermatitis (eczema). About 180 adolescent participants will receive the drug via injection to see if it reduces their skin inflammation and itching. The main goal is to check for side effects and measure improvements in eczema severity and quality of life over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University People's hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.